Literature DB >> 21098519

Parental preferences for FDA-approved medications prescribed for their children.

Esther Y Yoon1, Sarah J Clark, Amy Butchart, Dianne Singer, Matthew M Davis.   

Abstract

OBJECTIVE: To describe parental preferences for FDA-approved prescription medications for their children. STUDY
DESIGN: Cross-sectional Web-enabled survey of a national sample of 1562 parents.
RESULTS: Response rate was 61%. Most parents (77%) preferred prescription of only FDA-approved medications for their child. However, one half of parents preferred that their child's doctor prescribe medication that is safest and works best, even if not FDA approved for children. One third of parents (34%) preferred nothing but FDA-approved medications for their child, regardless of drug safety, effectiveness, or cost. Controlling for parent race and education, mothers (odds ratio = 1.52; P = .004) and older parents (odds ratio = 1.60; P = .025) were more likely to prefer nothing but FDA-approved medications for their children compared with fathers and younger parents.
CONCLUSIONS: Although most parents initially indicate preference for FDA-approved medications, one half of parents will accept a non-FDA-approved medication for their children with the understanding that it is safer or more effective than the FDA-approved alternative.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098519     DOI: 10.1177/0009922810385105

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  4 in total

1.  Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research.

Authors:  Angela S Czaja; Pamela D Reiter; M Lynn Schultz; Robert J Valuck
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

2.  Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.

Authors:  Greta A Bushnell; Scott N Compton; Stacie B Dusetzina; Bradley N Gaynes; M Alan Brookhart; John T Walkup; Moira A Rynn; Til Stürmer
Journal:  J Clin Psychiatry       Date:  2018 Jan/Feb       Impact factor: 4.384

3.  The best pharmaceuticals for children-what can we do?

Authors:  Hao Li; Fang-Hong Shi; Shi-Ying Huang; Shun-Guo Zhang; Hui-Wen Chen
Journal:  Transl Pediatr       Date:  2020-04

4.  Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.

Authors:  Janine Arnott; Hannah Hesselgreaves; Anthony J Nunn; Matthew Peak; Munir Pirmohamed; Rosalind L Smyth; Mark A Turner; Bridget Young
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.